Tech Company Financing Transactions

EPIRUS Biopharmaceuticals Funding Round

5AM Ventures, Montreux Equity Partners and private investors participated in a $8.1 million funding round for EPIRUS Biopharmaceuticals. This venture round was announced on 6/30/2012.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

699 Boylston Street 11th Floor
Boston, MA 02199
USA

Phone

Undisclosed

Website

www.epirusbiopharma.com

Email Address

[email protected]

Overview

The biopharmacuticals industry is approaching an unprecedented biologics patent cliff, with emerging markets forging their own regulatory landscapes. EPIRUS is seizing the opportunity with a new business model that adapts to the changing dynamics and regulations of today's market conditions.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Geoff Duyk

        

Chief Executive Officer

Amit Munshi

        

VP - Bus. Development

Gale Clark

        

VP - Bus. Development

Nick Plumeridge

        

VP - Manufacturing

Suman Patel

        

Browse more venture capital transactions:

Prev: 6/30/2012: ActaCell venture capital transaction
Next: 6/30/2012: Pivotal Systems venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary